1. Home
  2. MTRX vs VNDA Comparison

MTRX vs VNDA Comparison

Compare MTRX & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Matrix Service Company

MTRX

Matrix Service Company

HOLD

Current Price

$10.26

Market Cap

311.9M

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$8.74

Market Cap

474.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTRX
VNDA
Founded
1984
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
311.9M
474.0M
IPO Year
1995
2005

Fundamental Metrics

Financial Performance
Metric
MTRX
VNDA
Price
$10.26
$8.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$17.00
$14.90
AVG Volume (30 Days)
194.1K
3.7M
Earning Date
05-18-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$769,286,000.00
$216,105,000.00
Revenue This Year
$18.83
$21.50
Revenue Next Year
$9.35
$38.67
P/E Ratio
N/A
N/A
Revenue Growth
5.64
8.72
52 Week Low
$9.33
$3.81
52 Week High
$16.11
$9.91

Technical Indicators

Market Signals
Indicator
MTRX
VNDA
Relative Strength Index (RSI) 30.21 56.69
Support Level N/A $7.39
Resistance Level $12.75 $9.35
Average True Range (ATR) 0.48 0.57
MACD -0.03 0.13
Stochastic Oscillator 6.92 49.81

Price Performance

Historical Comparison
MTRX
VNDA

About MTRX Matrix Service Company

Matrix Service Co provides engineering, fabrication, construction, maintenance, and repair services prominently to the energy and industrial markets. The company operates through three main segments: Storage and Terminal Solutions, Utility and Power Infrastructure, and Process and Industrial Facilities. These segments cover services like building and maintaining storage tanks and terminals, supporting power delivery and new power generation projects including renewables, as well as plant maintenance and turnarounds for refining and petrochemical industries. Matrix generates revenue by delivering these services to clients in oil, gas, power, and petrochemical sectors across North America and internationally.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: